Foundation models of cancer biology to discover precision therapeutics.

A clinical-stage (Phase IIb cleared by the FDA) cell therapy company targeting neurodegenerative diseases (Progressive MS, ALS). To date, over 120 patients, and 6 published clinical trials have demons ...

N-Zyme Biomedical has identified a novel, causal mechanism of disease in reflux (LPR/GERD), owns the mechanism with its IP portfolio, and is rapidly developing clinical-stage assets. With near-term Ph ...

Nasus Pharma vision is to offer better protection to patients during acute, severe and life-threatening medical conditions by an effective, user-friendly, safe and immediately active powder-based Intr ...

The NSCEB is a legislative commission advising Congress on policies at the intersection of emerging biotechnology and national security.

Nob Hill Therapeutics, Inc. (NHT) is developing new therapies for lung-related diseases that cannot be effectively treated today.  

We are a research-driven investment bank focused on small cap emerging growth companies in the healthcare, technology, media and natural resources sectors.

NÖK Therapeutics, Inc. is a clinical-stage biotechnology innovator redefining the next generation of cancer immunotherapy by harnessing the innate power of natural killer (NK) cells. The company is fo ...

We are the policy and advocacy organization for the NC Life Sciences industry.